Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | 0.42 | 0.2 |
mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.073 | 0.2 |
mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.2 |
mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |